Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging features

Publication date: Available online 24 April 2019Source: Best Practice & Research Clinical RheumatologyAuthor(s): Mehdi Aoun Sebaiti, Marie Abrivard, Paul Blanc-Durand, Axel Van Der Gucht, Sarah Souvannanorath, Paul Kauv, Romain K. Gherardi, Emmanuel Itti, François Jérôme AuthierAbstractMacrophagic myofasciitis (MMF) syndrome is a subtype of autoimmune/inflammatory syndrome induced by adjuvants (ASIA) or Shoenfeld's syndrome, characterized by the presence of stereotyped inflammatory lesions at muscle biopsy attesting the long-term persistence of aluminum hydroxide particles at the site of previous immunization. Most frequently reported symptoms are chronic arthromyalgias and fatigue and cognitive complaint. MMF-associated cognitive disorder (MACD) is characterized by the dysfunctioning of attention, executive functions, short-term term and long-term memory, and, in some instances, left ear extinction. MACD is expressed in a chronic, nonevolving, well-defined syndromic framework within which the expression in terms of severity differs from one patient to another. While brain MRI is usually noncontributive, functional imaging using SPECT and PET has revealed the existence of a suggestive pathological pattern with involvement of posterior associative areas, temporal lobes, limbic system, and cerebellum. Put together, neuropsychological and functional neuroimaging investigations support the view that MACD relates to organic central nervous system involvement.
Source: Best Practice and Research Clinical Rheumatology - Category: Rheumatology Source Type: research